Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med. 2013;5:179ps7 https://doi.org/10.1126/scitranslmed.3005568.
Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77. https://doi.org/10.1056/NEJM199811263392201.
Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–22. https://doi.org/10.1056/NEJM200106143442402.
Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–89. https://doi.org/10.1182/blood-2008-03-140830.
Shearer WT, Lubin BH, Cairo MS, Notarangelo LD Cord Blood Banking for Potential Future Transplantation. Pediatrics. 2017;140. https://doi.org/10.1542/peds.2017-2695.
Ballen K. Umbilical Cord Blood Transplantation: Challenges and Future Directions. Stem Cells Transl Med. 2017;6:1312–5. https://doi.org/10.1002/sctm.17-0069.
Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr. 2014;164:973–79. https://doi.org/10.1016/j.jpeds.2013.11.036.
Laskowitz DT, Bennett ER, Durham RJ, Volpi JJ, Wiese JR, Frankel M, et al. Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. Stem Cells Transl Med. 2018;7:521–9. https://doi.org/10.1002/sctm.18-0008.
Dawson G, Sun JM, Davlantis KS, Murias M, Franz L, Troy J, et al. Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial. Stem Cells Transl Med. 2017;6:1332–9. https://doi.org/10.1002/sctm.16-0474.
Sun JM, Song AW, Case LE, Mikati MA, Gustafson KE, Simmons R, et al. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. Stem Cells Transl Med. 2017;6:2071–8. https://doi.org/10.1002/sctm.17-0102.
Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22:3192–202. https://doi.org/10.1089/scd.2013.0023.
Gao LR, Chen Y, Zhang NK, Yang XL, Liu HL, Wang ZG, et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015;13:162 https://doi.org/10.1186/s12916-015-0399.
Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C. et al.Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). Circ Res.2017;121:1192–1204.
Xie B, Gu P, Wang W, Dong C, Zhang L, Zhang J, et al. Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy. Am J Transl Res. 2016;8:3241–50.
Götherström C, Westgren M, Shaw SW, Aström E, Biswas A, Byers PH, et al. Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med. 2014;3:255–64. https://doi.org/10.5966/sctm.2013-0090.
Murphy S, Rosli S, Acharya R, Mathias L, Lim R, Wallace E, et al. Amnion epithelial cell isolation and characterization for clinical use. Curr Protoc Stem Cell Biol. 2010; Chapter 1:1 https://doi.org/10.1002/9780470151808.sc01e06s13.
Phan TG, Ma H, Lim R, Sobey CG, Wallace EM. Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke. Front Neurol. 2018;9:198 https://doi.org/10.3389/fneur.2018.00198.
Lim R, Malhotra A, Tan J, Chan ST, Lau S, Zhu D, et al. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study. Stem Cells Transl Med. 2018;7:628–35. https://doi.org/10.1002/sctm.18-0079.
Baker EK, Malhotra A, Lim R, Jacobs SE, Hooper SB, Davis PG, et al. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. BMJ Open. 2019;9:e026265 https://doi.org/10.1136/bmjopen-2018-026265.
Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8. https://doi.org/10.1056/NEJM198910263211707.
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–8. https://doi.org/10.1182/blood-2013-02-453175.
Global Cord Blood & Tissue Industry Database. Bioinformant. https://bioinformant.com/product/global-cord-blood-industry-database/. Published 2020.
Lubin BH, Shearer WT. Cord blood banking for potential future transplantation. Pediatrics. 2007;119:165–70. https://doi.org/10.1542/peds.2006-2901.
Kurtzberg J. A History of Cord Blood Banking and Transplantation. Stem Cells Transl Med. 2017;6:1309–11. https://doi.org/10.1002/sctm.17-0075.
Ballen KK, Verter F, Kurtzberg J. Umbilical cord blood donation: public or private? Bone Marrow Transplant. 2015;50:1271–8. https://doi.org/10.1038/bmt.2015.124.
Hollands P, McCauley C. Private cord blood banking: current use and clinical future. Stem Cell Rev reports. 2009;5:195–203. https://doi.org/10.1007/s12015-009-9082-0.
Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S. Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics. 2009;123:1011–7. https://doi.org/10.1542/peds.2008-0436.
Huang L, Zhang C, Gu J, Wu W, Shen Z, Zhou X, et al. A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy. Cell Transplant. 2018;27:325–34. https://doi.org/10.1177/0963689717729379.
Min K, Song J, Kang JY, Ko J, Ryu JS, Kang MS, et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial. Stem Cells. 2013;31:581–91. https://doi.org/10.1002/stem.1304.
Kang M, Min K, Jang J, Kim SC, Kang MS, Jang SJ, et al. Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy. Stem Cells Dev. 2015;24:2259–68. https://doi.org/10.1089/scd.2015.0074.
Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, Schatz D, et al. Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial. Pediatr Diabetes. 2014;15:100–9. https://doi.org/10.1111/pedi.12072.
Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, et al. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biol Blood Marrow Transplant. 2013;19:1126–9. https://doi.org/10.1016/j.bbmt.2013.04.011.
Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Yin Z, et al. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med. 2012;10:3 https://doi.org/10.1186/1741-7015-10-3.
O’Connor MAC, Samuel G, Jordens CFC, Kerridge IH. Umbilical cord blood banking: beyond the public-private divide. J Law Med. 2012;19:512–6.
Hauskeller C, Beltrame L. The hybrid bioeconomy of umbilical cord blood banking: Re-examining the narrative of opposition between public and private services. Biosocieties. 2016;11:415–34. https://doi.org/10.1057/biosoc.2015.45.
Fisk NM, Atun R. Public-private partnership in cord blood banking. BMJ. 2008;336:642–4. https://doi.org/10.1136/bmj.39489.454699.
NetCord‐FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. 2019. https://www.factweb.org/forms/store/ProductFormPublic/seventh-edition-netcord-fact-international-standards-for-cord-blood-collection-banking-and-release-for-administration-free-download.
Omori A, Hirai M, Chiba T, Takahashi K, Yamaguchi S, Takahashi TA, et al. Quality-assessments of characteristics of placental/umbilical cord blood associated with maternal age- and parity-related factor. Transfus Apher Sci. 2012;46:7–13. https://doi.org/10.1016/j.transci.2011.10.030.
Urciuoli P, Passeri S, Ceccarelli F, Luchetti B, Paolicchi A, Lapi S, et al. Pre-birth selection of umbilical cord blood donors. Blood Transfus. 2010;8:36–43. https://doi.org/10.2450/2009.0081-09.
Jaime-Perez JC, Monreal-Robles R, Colunga-Pedraza J, Mancías-Guerra C, Rodríguez-Romo L, Gómez-Almaguer D. Cord blood banking activities at a university hospital in northeast Mexico: an 8-year experience. Transfusion. 2012;52:2606–13. https://doi.org/10.1111/j.1537-2995.2012.03638.
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–7. https://doi.org/10.1182/blood-2004-07-2717.
Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368–76. https://doi.org/10.1053/bbmt.2002.v8.pm12171483.
de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008;41:771–8. https://doi.org/10.1038/sj.bmt.1705979.
Horwitz ME, Chao NJ, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest. 2014;124:3121–8. https://doi.org/10.1172/JCI74556.
Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061–7. https://doi.org/10.1182/blood-2001-12-0290.
Xue C, Kwek KYC, Chan JKY, Chen Q, Lim M. The hollow fiber bioreactor as a stroma-supported, serum-free ex vivo expansion platform for human umbilical cord blood cells. Biotechnol J. 2014;9:980–9. https://doi.org/10.1002/biot.201300320.
Bari S, Seah KK, Poon Z, Cheung AM, Fan X, Ong SY, et al. Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation. Biol Blood Marrow Transplant. 2015;21:1008–19. https://doi.org/10.1016/j.bbmt.2014.12.022.
Teofili L, Silini AR, Bianchi M, Valentini CG, Parolini O. Incorporating placental tissue in cord blood banking for stem cell transplantation. Expert Rev Hematol. 2018;11:649–61. https://doi.org/10.1080/17474086.2018.1483717.
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final Data for 2017. Natl Vital Stat Rep. 2018;67:1–50.
Guerrero EN, Vega S, Fu C, De León R, Beltran D, Solis MA. Increased proliferation and differentiation capacity of placenta-derived mesenchymal stem cells from women of median maternal age correlates with telomere shortening. Aging (Albany NY). 2021;13:24542–59. https://doi.org/10.18632/aging.203724.
Gil-Kulik P, Świstowska M, Krzyżanowski A, Petniak A, Kwaśniewska A, Płachno BJ, et al. Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton’s Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23147630.
Alrefaei GI, Ayuob NN, Ali SS, Al-Karim S. Effects of maternal age on the expression of mesenchymal stem cell markers in the components of human umbilical cord. Folia Histochem Cytobiol. 2015;53:259–71. https://doi.org/10.5603/FHC.a2015.0022.
Ballen KK, Wilson M, Wuu J, Ceredona AM, Hsieh C, Stewart FM, et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant. 2001;27:7–14. https://doi.org/10.1038/sj.bmt.1702729.
McGuckin CP, Basford C, Hanger K, Habibollah S, Forraz N. Cord blood revelations—The importance of being a first born girl, big, on time and to a young mother! Early Hum Dev. 2007;83:733–41. https://doi.org/10.1016/j.earlhumdev.2007.09.001.
Londero AP, Rossetti E, Pittini C, Cagnacci A, Driul L. Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study. BMC Pregnancy Childbirth. 2019;19:261 https://doi.org/10.1186/s12884-019-2400.
Kenny LC, Lavender T, McNamee R, O’Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS One. 2013;8:e56583 https://doi.org/10.1371/journal.pone.0056583.
Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. PLoS One. 2017;12:e0186287 https://doi.org/10.1371/journal.pone.0186287.
Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, Vogel JP, et al. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG. 2014;121:49–56. https://doi.org/10.1111/1471-0528.12659.
Ciubotariu R, Scaradavou A, Ciubotariu I, Tarnawski M, Lloyd S, Albano M, et al. Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors? Transfusion. 2018;58:1427–33. https://doi.org/10.1111/trf.14574.
MacDorman MF, Declercq E. Trends and state variations in out-of-hospital births in the United States, 2004-2017. Birth. 2019;46:279–88. https://doi.org/10.1111/birt.12411.
Australain R. New Zealand Colleges of Obstetricians and Gynaecologists. Home Birth C-Obs 2 (2017). 2017;42:1–11.
Davies-Tuck ML, Wallace EM, Davey M-A, Veitch V, Oats J. Planned private homebirth in Victoria 2000–2015: a retrospective cohort study of Victorian perinatal data. BMC Pregnancy Childbirth. 2018;18:357 https://doi.org/10.1186/s12884-018-1996-6.
de Jonge A, Geerts CC, van der Goes BY, Mol BW, Buitendijk SE, Nijhuis JG. Perinatal mortality and morbidity up to 28 days after birth among 743 070 low-risk planned home and hospital births: a cohort study based on three merged national perinatal databases. BJOG. 2015;122:720–8. https://doi.org/10.1111/1471-0528.13084.
Preterm Birth. 19th Feb 2018. World Health Organisation. 2018.
Solves P, López M, Mirabet V, Blanquer A, Roig R, Perales A. Characteristics of umbilical cord blood units collected from preterm deliveries. Gynecol Obstet Invest. 2009;68:181–5. https://doi.org/10.1159/000232382.
Surbek DV, Holzgreve W, Steinmann C, Hahn S, Gratwohl A, Wodnar-Filipowicz A, et al. Preterm birth and the availability of cord blood for HPC transplantation. Transfusion. 2000;40:817–20. https://doi.org/10.1046/j.1537-2995.2000.40070817.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8. https://doi.org/10.1182/blood-2002-01-0294.
Purtill D, Smith K, Devlin S, Meagher R, Tonon J, Lubin M, et al. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood. 2014;124:2905–12. https://doi.org/10.1182/blood-2014-03-566216.
Wyrsch A, dalle Carbonare V, Jansen W, Chklovskaia E, Nissen C, Surbek D, et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol. 1999;27:1338–45. https://doi.org/10.1016/s0301-472x(99)00059-4.
Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med. 2009;180:454–61. https://doi.org/10.1164/rccm.200901-0115OC.
Balgi-Agarwal S, Winter C, Corral A, Mustafa SB, Hornsby P, Moreira A. Comparison of Preterm and Term Wharton’s Jelly-Derived Mesenchymal Stem Cell Properties in Different Oxygen Tensions. Cells Tissues Organs. 2018;205:137–50. https://doi.org/10.1159/000489256.
Chaubey S, Thueson S, Ponnalagu D, Alam MA, Gheorghe CP, Aghai Z, et al. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther. 2018;9:173 https://doi.org/10.1186/s13287-018-0903-4.
Li J, Yawno T, Sutherland A, Loose J, Nitsos I, Allison BJ, et al. Term vs. preterm cord blood cells for the prevention of preterm brain injury. Pediatr Res. 2017;82:1030–8. https://doi.org/10.1038/pr.2017.170.
Zhu D, Kusuma GD, Schwab R, Chan ST, Tan J, Saad MI, et al. Prematurity negatively affects regenerative properties of human amniotic epithelial cells in the context of lung repair. Clin Sci (Lond). 2020;134:2665–79. https://doi.org/10.1042/CS20200859.
Kotowski M, Litwinska Z, Klos P, Pius-Sadowska E, Zagrodnik-Ulan E, Ustianowski P, et al. Autologous cord blood transfusion in preterm infants – could its humoral effect be the kez to control prematurity-related complications? A preliminary study. J Physiol Pharmacol an Off J Polish Physiol Soc. 2017;68:921–7.
Khodabux CM, von Lindern JS, van Hilten JA, Scherjon S, Walther FJ, Brand A. A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity. Transfusion. 2008;48:1634–43. https://doi.org/10.1111/j.1537-2995.2008.01747.
Brune T, Garritsen H, Hentschel R, Louwen F, Harms E, Jorch G. Efficacy, recovery, and safety of RBCs from autologous placental blood: clinical experience in 52 newborns. Transfusion. 2003;43:1210–6. https://doi.org/10.1046/j.1537-2995.2003.00503.
Vogel JP, Souza JP, Mori R, Morisaki N, Lumbiganon P, Laopaiboon M, et al. Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121:76–88. https://doi.org/10.1111/1471-0528.12633.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet (London, England). 2006;367:1066–74. https://doi.org/10.1016/S0140-6736(06)68397-9.
Krielessi V, Papantoniou N, Papageorgiou I, Chatzipapas I, Manios E, Zakopoulos N, et al. Placental Pathology and Blood Pressure’s Level in Women with Hypertensive Disorders in Pregnancy. Obstet Gynecol Int. 2012;2012:684083 https://doi.org/10.1155/2012/684083.
Pediatrics AAo. National high blood pressure education program working group on high blood pressure in children and adolescents. Pediatrics. 2004;114:iv–iv.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1–7. https://doi.org/10.1016/j.ejogrb.2013.05.005.
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet (London, England). 2016;387:999–1011. https://doi.org/10.1016/S0140-6736(15)00070-7.
Xia L, Zhou XP, Zhu JH, Xie XD, Zhang H, Wang XX, et al. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J Obstet Gynaecol Res. 2007;33:465–74. https://doi.org/10.1111/j.1447-0756.2007.00555.
Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol. 2006;56:79–85. https://doi.org/10.1111/j.1600-0897.2006.00387.
Hwang JH, Lee MJ, Seok OS, Paek YC, Cho GJ, Seol HJ, et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine. 2010;49:95–101. https://doi.org/10.1016/j.cyto.2009.08.013.
Kusuma GD, Abumaree MH, Perkins AV, Brennecke SP, Kalionis B. Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists. Sci Rep. 2017;7:42397. https://doi.org/10.1038/srep42397.
Juber NF, Abdulle A, AlJunaibi A, AlNaeemi A, Ahmad A, Leinberger-Jabari A, et al. Maternal Early-Life Risk Factors and Later Gestational Diabetes Mellitus: A Cross-Sectional Analysis of the UAE Healthy Future Study (UAEHFS). Int J Environ Res Public Health. 2022;19. https://doi.org/10.3390/ijerph191610339.
Acosta JC, Haas DM, Saha CK, Dimeglio LA, Ingram DA, Haneline LS. Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets. Am J Obstet Gynecol. 2011;204:254.e8–254.e15. https://doi.org/10.1016/j.ajog.2010.10.913.
Wajid N, Naseem R, Anwar SS, Awan SJ, Ali M, Javed S, et al. The effect of gestational diabetes on proliferation capacity and viability of human umbilical cord-derived stromal cells. Cell Tissue Bank. 2015;16:389–97. https://doi.org/10.1007/s10561-014-9483-4.
Kim J, Piao Y, Pak YK, Chung D, Han YM, Hong JS, et al. Umbilical cord mesenchymal stromal cells affected by gestational diabetes mellitus display premature aging and mitochondrial dysfunction. Stem Cells Dev. 2015;24:575–86. https://doi.org/10.1089/scd.2014.0349.
Mathew SA, Bhonde R. Mesenchymal stromal cells isolated from gestationally diabetic human placenta exhibit insulin resistance, decreased clonogenicity and angiogenesis. Placenta. 2017;59:1–8. https://doi.org/10.1016/j.placenta.2017.09.002.
Chen L, Merkhan MM, Forsyth NR, Wu P. Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities. Stem Cell Res. 2019;40:101537. https://doi.org/10.1016/j.scr.2019.101537.
Drake P, Driscoll AK, Mathews TJ. Cigarette Smoking During Pregnancy: United States, 2016. NCHS Data Brief. 2018;1–8, no 305.
Rua Ede A, Porto ML, Ramos JP, Nogueira BV, Meyrelles SS, Vasquez EC, Pereira TC. Effects of tobacco smoking during pregnancy on oxidative stress in the umbilical cord and mononuclear blood cells of neonates. J Biomed Sci. 2014;21:105. https://doi.org/10.1186/s12929-014-0105.
Baergen RN. Manual of pathology of the human placenta. Springer Science & Business Media; 2011.
Gaccioli F, Lager S. Placental Nutrient Transport and Intrauterine Growth Restriction. Front Physiol. 2016;7:40 https://doi.org/10.3389/fphys.2016.00040.
Mandò C, Razini P, Novielli C, Anelli GM, Belicchi M, Erratico S, et al. Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction. Stem Cells Transl Med. 2016;5:451–63. https://doi.org/10.5966/sctm.2015-0155.
Sipos PI, Bourque SL, Hubel CA, Baker PN, Sibley CP, Davidge ST, et al. Endothelial Colony-Forming Cells Derived From Pregnancies Complicated by Intrauterine Growth Restriction Are Fewer and Have Reduced Vasculogenic Capacity. J Clin Endocrinol Metab. 2013;98:4953–60. https://doi.org/10.1210/jc.2013-2580.
James JL, Srinivasan S, Alexander M, Chamley LW. Can we fix it? Evaluating the potential of placental stem cells for the treatment of pregnancy disorders. Placenta. 2014;35:77–84. https://doi.org/10.1016/j.placenta.2013.12.010.
Okun N, Sierra S. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Canada. 2014;36:64–83. https://doi.org/10.1016/S1701-2163(15)30685.
Datta J, Palmer MJ, Tanton C, Gibson LJ, Jones KG, Macdowall W, et al. Prevalence of infertility and help seeking among 15 000 women and men. Hum Reprod. 2016;31:2108–18. https://doi.org/10.1093/humrep/dew123.
Oakley L, Doyle P, Maconochie N. Lifetime prevalence of infertility and infertility treatment in the UK: results from a population-based survey of reproduction. Hum Reprod. 2008;23:447–50. https://doi.org/10.1093/humrep/dem369.
Lui Yovich J. Founding pioneers of IVF update: Innovative researchers generating livebirths by 1982. Reprod Biol. 2020;20:111–3. https://doi.org/10.1016/j.repbio.2019.12.008.
Banker M, Mehta V, Sorathiya D, Dave M, Shah S. Pregnancy outcomes and maternal and perinatal complications of pregnancies following in vitro fertilization/intracytoplasmic sperm injection using own oocytes, donor oocytes, and vitrified embryos: A prospective follow-up study. J Hum Reprod Sci. 2016;9:241–9. https://doi.org/10.4103/0974-1208.197666.
Luke B, Gopal D, Cabral H, Stern JE, Diop H. Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol. 2017;217:327. https://doi.org/10.1016/j.ajog.2017.04.006.
Sciascia S, Hunt BJ, Talavera-Garcia E, Lliso G, Khamashta MA, Cuadrado MJ. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol. 2016;214:273. https://doi.org/10.1016/j.ajog.2015.09.078.
Breton M-C, Beauchesne M-F, Lemière C, Rey É, Forget A, Blais L. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy. J Allergy Clin Immunol. 2010;126:772–777. https://doi.org/10.1016/j.jaci.2010.08.018.
Mandel SJ. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: maternal aspects. Best Pract Res Clin Endocrinol Metab. 2004;18:213–24. https://doi.org/10.1016/j.beem.2004.03.006.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41434-023-00426-w